For an herb that has been around
for centuries and used by so many people without adverse effects, one might
think that stevia would be a welcome addition to the roster of commonly
accepted foods. Instead, its exceptional sweetness has made it the subject
of much Kafka-type intrigue involving the FDA -- even after passage of
legislation that allowed it to be marketed as a dietary supplement.
The stevia story -- which had previously
been characterized by official ambiguity, secret “trade complaints,” a
full-fledged "import alert," and FDA searches and seizures -- took another
bizarre turn in May of '98 when the FDA directed a Texas-based distributor
of stevia dietary supplements, Stevita Company, to destroy three
books on its history, benefits and uses. (One of the books targeted by
the FDA was "The Stevia Story; A tale of incredible sweetness &
intrigue" by Linda and Bill Bonvie and Donna Gates). The directive was
the result of a determination that literature describing stevia’s sweetening
capabilities somehow violated a ban on the labeling of such supplements
as sweeteners.
In a letter to the company president, FDA
compliance officer James R. Lahar wrote that an investigator would not
only be coming around to take a current inventory, but would also “be available
to witness the destruction of the cookbooks, literature and other publications
for the purpose of verifying compliance.”
Destruction of literature? It was what
the FDA later conceded was an “inartfully worded” statement -- that is,
worded in such a manner so as to pose a threat to the entire herbal industry.
It was also the kind of language that hit the media right where it lives
in the shelter of the First Amendment.
With the smell of burning books in the
air, the Texas division of the American Civil Liberties Union became involved
in the issue, as did media ranging from the Christian Broadcasting Network
to newspapers in Texas, New Jersey and Wyoming. The story hit the
Internet big time, with numerous news group postings and Web sites reporting
on the situation.
Besieged by calls from reporters, the FDA
changed its tune. In a letter to the firm that June, the agency authorized
the release of the company’s stevia dietary supplement products from detention,
and maintained it had “no issues” with two of the books.